Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Summary

GlobalData, the industry analysis specialist, has released its latest report: “Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Netherlands pharmaceutical market grew from €4.61B in 2012 to €4.64B in 2018 at a Compound Annual Growth Rate (CAGR) of 0.12%. However, in terms of USD, the pharmaceutical market decreased from $5.92B in 2012 to $5.48B in 2018, at a negative CAGR of 1.27%. This difference is due to currency exchange fluctuations. The pharmaceutical market is expected to reach $5.01B in 2025. The Netherlands’ robust healthcare system and growing investment in R&D are driving the pharmaceutical market. However, reimbursement policies favoring the usage of generics is restricting pharmaceutical market growth.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Netherlands, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, GSK, Sanofi, Pfizer, and AstraZeneca
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, GE Healthcare, Fresenius, Roche Diagnostics, and Alcon
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in The Netherlands healthcare market
Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Netherlands’ healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Netherlands’ healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership


1. Table of Contents
1.1List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Netherlands Healthcare Market
2.3 Key Highlights: Healthcare Startups in The Netherlands
2.4 Key Events: the Netherlands Healthcare Timeline, 2014-2020
2.5 Key Events: the Netherlands Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, The Netherlands, 2019
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, The Netherlands
3.5 Pharmaceutical Market - Market Segments
3.6 COVID-19 Epidemiology, The Netherlands
3.7 COVID-19 Impact and Developments in the Healthcare Market, The Netherlands
3.8Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, The Netherlands, 2019-2020
7. HealthTech Landscape
7.1 HealthTech Deals Landscape, The Netherlands
7.2 Key HealthTech Deals, The Netherlands
7.3 Adoption of Technology in Healthcare, The Netherlands
7.4 Regulatory Scenario Covering Use of Technology in Healthcare, the Netherlands
7.5 HealthTech Landscape - Benefits and Risks, the Netherlands
8. Market Access
8.1 Overview of Healthcare System, The Netherlands
8.2 Reimbursement and Payer Landscape, The Netherlands
8.3 Reimbursement Process, The Netherlands
8.4 Overview of Insurance Providers, The Netherlands
8.5 Healthcare Spending and Medicine Price Index, The Netherlands
8.5 Pricing Policies, The Netherlands
8.6 Regulatory Landscape, The Netherlands
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, The Netherlands
8.6.3 Market Authorization for Medical Devices, The Netherlands
8.6.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing,
the Netherlands
8.6.5 Licensing Process for Pharmaceutical Exports and Imports, the Netherlands
8.6.6 Intellectual Property Rights, Patent, The Netherlands
8.6.7 Intellectual Property Rights, Trademark, The Netherlands
8.6.8 Clinical Trials Regulation, The Netherlands
8.6.9 Pharmaceutical Clinical Trials Landscape, The Netherlands
8.6.10 Medical Devices Clinical Trials Landscape, The Netherlands
8.6.11COVID-19 Clinical Trials Landscape, The Netherlands
8.6.12 Pharmaceutical Advertisement Regulations, The Netherlands
8.6.13 Pharmacy Regulations, The Netherlands
8.6.14 Labeling and Packaging Regulations, The Netherlands
9. Country Healthcare Landscape
9.1 Healthcare Facilities, The Netherlands
9.2 Healthcare Parameters, The Netherlands
9.3 Life Expectancy and Immunization Rate, The Netherlands
9.4 Environmental Health, The Netherlands
9.5 Healthcare Personnel, The Netherlands
9.6 Disease Burden, The Netherlands
9.7 Healthcare Expenditure, The Netherlands
10 Trade Associations, The Netherlands
11 Trade Fairs, The Netherlands
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer
List of Tables
Table 1: Approved Biosimilars, the Netherlands, 2016
Table 2: COVID-19 Indicators (Number of cases), Global and the Netherlands, 2020
Table 3: COVID-19 IVD Products, The Netherlands, 2020
Table 4: Medical Device Market, the Netherlands, Major Segments ($M), 2019
Table 5: Ophthalmic Devices Market, the Netherlands, Revenue ($M) and Market Share (%) of Major Players, 2019
Table 6: General Surgery Market, the Netherlands, Revenue ($M) and Market Share (%) of Major Players, 2019
Table 7: Orthopedic Devices Market, the Netherlands, Revenue ($M) and Market Share (%) of Major Players, 2019
Table 8: Healthcare IT Market, the Netherlands, Revenue ($M) and Market Share (%) of Major Players, 2019
Table 9: Woundcare Management Devices Market, the Netherlands, Revenue ($M) and Market Share (%) of Major Players, 2019
Table 10: Classification of Medical Device, the Netherlands, 2020
Table 11: Outer Label, the Netherlands, 2020
List of Figures
Figure 1: Pharmaceutical Market, the Netherlands, Revenue ($B), 2012-2019
Figure 2: Medical Device Market, the Netherlands, Revenue ($B), 2015-202
Figure 3: Healthcare Startups in the Netherlands, 2020
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, the Netherlands, 2019
Figure 7: Pharmaceutical Market, the Netherlands, Revenue ($B), 2012-2019
Figure 8: Pharmaceutical Market, the Netherlands, Revenue Forecast ($B), 2020-2024
Figure 9: Pharmaceutical Exports ($B), the Netherlands, 2012-2019
Figure 10: Top Export Partners, the Netherlands, 2019
Figure 11: Pharmaceutical Imports ($B), the Netherlands, 2012-2019
Figure 12: Top Import Partners, the Netherlands, 2019
Figure 13: Supply Channels, the Netherlands, 2019
Figure 14: Market Share of Generics Drugs (Value and Volume, %), the Netherlands, 2019
Figure 15: OTC Market, the Netherlands, Revenue ($B), 2012-2018
Figure 16: OTC Market by Drug Category, the Netherlands, Revenue ($M), 2018
Figure 17: COVID-19 (Cases), the Netherlands, 2020
Figure 18: COVID-19 (Deaths), the Netherlands, 2020
Figure 19: Medical Device Market, the Netherlands, Revenue ($B), 2015-2020
Figure 20: Medical Device Market, the Netherlands, Revenue Forecast ($B), 2021-2025
Figure 21: Medical Device Market, the Netherlands, Major Segments (%), 2019
Figure 22: Ophthalmic Devices Market, the Netherlands, Revenue ($M), 2015-2022
Figure 23: Ophthalmic Devices Market, the Netherlands, Market Share of Major Players (%), 2019
Figure 24: General Surgery Market, the Netherlands, Revenue ($M), 2015-2022
Figure 25: General Surgery Market, the Netherlands, Market Share of Major Players (%), 2019
Figure 26: Orthopedic Devices Market, the Netherlands, Revenue ($M), 2015-2022
Figure 27: Orthopedic Devices Market, the Netherlands, Market Share of Major Players (%), 2019
Figure 28: Healthcare IT Market, the Netherlands, Revenue ($M), 2015-2022
Figure 29: Healthcare IT Market, the Netherlands, Market Share of Major Players (%), 2019
Figure 30: Wound Care Management Market, the Netherlands, Revenue ($M), 2015-2022
Figure 31: Wound Care Management Market, the Netherlands, Market Share of Major Players (%), 2019
Figure 32: Diagnostic Market, the Netherlands, Revenue ($M), 2015-2020
Figure 33: Diagnostic Market, the Netherlands, Revenue ($M), 2021-2025
Figure 34: Medical Devices Market, the Netherlands, Revenue ($B) of Major Companies, 2019
Figure 35: Deal Value and Deal Count, Pharmaceutical Market, the Netherlands, 2019-2020
Figure 36: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, the Netherlands, 2019-2020
Figure 37: Deal Value and Deal Count, Subtypes, Pharmaceutical Market, the Netherlands, 2019-2020
Figure 38: Deal Value ($M), HealthTech, the Netherlands, 2019-2020
Figure 39: Deal Count ($M), HealthTech, the Netherlands, 2019-2020
Figure 40: Organization of Health System, the Netherlands, 2019
Figure 41: Drug Reimbursement Process, the Netherlands, 2019
Figure 42: OOP Expenditure (% of total expenditure on health), the Netherlands, 2012-2019
Figure 43: Annual Rate of Change (%), Health Price Index, the Netherlands, 2012-2019
Figure 44: EMA Drug Approval Process, the Netherlands, 2019
Figure 45: Centralized Procedure, the Netherlands, 2020
Figure 46: Decentralized Procedure, the Netherlands, 2020
Figure 47: Mutual Recognition Procedure, the Netherlands, 2020
Figure 48: European Patent Approval Process, the Netherlands, 2020
Figure 49: Pharmaceutical Clinical Trials Count by Trial Status, the Netherlands, 2019-2020
Figure 50: Pharmaceutical Clinical Trials Count by Phase, the Netherlands, 2019-2020
Figure 51: Pharmaceutical Clinical Trials Count by Indication, the Netherlands, 2019-2020
Figure 52: Top Five Pharmaceutical Clinical Trials Sponsors by Count, the Netherlands, 2019-2020

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook